Acarix announces outcome of warrant exercise of series 3
Acarix AB ("Acarix" or the "Company") today announces the outcome of the exercise of warrants of series 3 issued in connection with the...
Acarix informs of exercise price for the warrants of series TO 3
Acarix AB ("Acarix" or the "Company"), a leader in rapid AI and acoustics-based cardiac diagnostics, announces that the exercise price ...
Acarix AB (publ) publishes Interim Report, April – June 2024
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the second quarter of 20...
Announcement from the annual general meeting in Acarix AB
The annual general meeting 2024 (the "AGM") of Acarix AB ("Acarix" or the "Company") was held today on 14 May 2024 and the following re...
Kommuniké från årsstämma i Acarix AB
Årsstämman 2024 i Acarix AB ("Acarix" eller "Bolaget") hölls idag den 14 maj 2024 varvid aktieägarna fattade f&oum...
Acarix AB (publ) publishes Interim Report, January – March 2024
Setting the stage for a strong 2024 and beyondOne of the most notable achievements this quarter has been the successful implementation ...
Proposal by the nomination committee prior to the 2024 annual general meeting of Acarix AB (publ)
The Nomination Committee of Acarix consists of Jan Poulsen (Chairman) representing Life Science Invest Fund 1 among others, Anton Rehns...
Acarix AB’s Annual Report 2023
Acarix, a leader in advanced acoustic-based cardiac diagnostics, today announces that the Annual Report for 2023 is available as a pdf ...
Acarix AB’s Årsredovisning 2023
Acarix, ledande inom avancerad akustikbaserad hjärtdiagnostik, meddelar idag att årsredovisning för 2023 finns tillg&au...
NOTICE OF ANNUAL GENERAL MEETING IN ACARIX AB
The shareholders of Acarix AB, reg. no. 559009-0667 (the "Company"), are hereby invited to the annual general meeting on Tuesday 14 May...
KALLELSE TILL ÅRSSTÄMMA I ACARIX AB
Aktieägarna i Acarix AB, org.nr 559009-0667 ("Bolaget"), kallas härmed till årsstämma tisdagen den 14 maj 2024 kl....
Acarix announces the outcome of the exercise of warrants of series 2024:U1 (TO2)
The Board of directors of Acarix AB ("Acarix" or the "Company") today announces the outcome of the exercise period for warrants of seri...